Astellas
Focus: Astellas is a 5,000+ employee biopharmaceutical company headquartered in Shenyang, China, operating across small molecules, ADCs, cell therapy, gene therapy, and antibodies. It maintains a diversified pipeline while generating substantial revenue from established oncology and specialty care products.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Employees
5000+
Open Jobs
0
About Astellas
AI assessmentNot HiringNo open roles listed right now. Follow Astellas to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthWatch
Pipeline
Early-stage
50 total
LOE Risk
6 imminent
CRESEMBA
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$2.6BStable
Peak10.6yr
Flagship product generating 96% of company revenue; patent protected for 11+ years ensures sustained funding and profitability.
Help build intelligence for Astellas
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.